Heart Disease Trial, Recruiting NCT06829160 Sponsor: NYU Langone Health Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06829160
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 and over
  • People who have been diagnosed with Ischemia with Non-Obstructive Coronary Arteries (INOCA) — a heart condition where there are signs of reduced blood flow to the heart, but the main heart arteries are not significantly blocked — confirmed through a CT scan or a procedure that looks inside the arteries

Who may not be able to join:

  • People who scored a perfect 100 on a heart symptom questionnaire called the Seattle Angina Questionnaire, meaning they have no angina-related limitations or symptoms
  • People who are not able to walk or move around independently
  • People who are pregnant
  • People with moderate or severe difficulties with memory or thinking
  • People who are not able or not willing to give their consent to participate
  • People who are currently incarcerated
  • People who are not able to use a mobile health (mHealth) app on a smartphone or similar device
  • People with severe osteoarthritis, or who have had a joint replacement surgery within the past 3 months
  • People with Parkinson's disease or other conditions that affect movement
  • People who regularly use a walker to get around
  • People with a life expectancy of less than 12 months
  • People where the treating doctor has concerns about safety or the likelihood of being able to follow the trial requirements
  • People who are not able to read and communicate in English, as the app used in this trial is currently only available in English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Harmony Reynolds, MD, NYU Langone Health

Phone: 212-263-7751

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 March 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Seattle Angina Questionnaire (SAQ) score; Change in Seattle Angina Questionnaire (SAQ) score; Weekly percent completion of the mHealth-CR program

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov